Ligand Pharmaceuticals Inc (LGND)
Stock-Based Compensation
$53.27M
TTM · Period ending: · USD
LGND Stock-Based Compensation
Latest reported$53.27Mperiod ending
Latest reported$53.27Mperiod ending
LGND Stock-Based Comp ($0.00 → $53.27M)
Annual stock-based compensation
High-resolution chart · PNG
LGND stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 0 | |
| 41,089,000 | |
| 25,743,000 | |
| 60,285,000 | |
| 38,783,000 | |
| 30,727,000 | |
| 24,515,000 | |
| 20,846,000 | |
| 24,915,000 | |
| 18,893,000 | |
| 12,458,000 | |
| 11,270,000 | |
| 5,666,000 | |
| 4,067,000 | |
| 3,351,000 | |
| 2,325,000 | |
| 3,365,000 | |
| -537,000 | |
| 7,580,000 | |
| 5,338,000 | |
| 107,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |